Importantly, we demonstrated concomitantly high expression of Zeb1 and NICD in breast cancer patients with poorly differentiated high-grade tumors (Fig. 7e), highlighting that dysregulated Notch1-Zeb1 signaling is functionally linked to tumor stem cell traits in breast cancer. The gene discussed is ZEB1; the disease is neoplasm.